CompletedNot Applicable

Can Mindfulness and Self-monitoring Improve Control Over Maladaptive Daydreaming?

Israel697 participantsStarted 2018-12-20

Plain-language summary

Maladaptive daydreaming (MD) is a compulsive form of daydreaming that causes distress and functional impairment among tens of thousands of self-diagnosed sufferers. This is the first controlled treatment trial for MD. The investigators built an internet-based self-help program for MD and tested the effectiveness of mindfulness and self-monitoring in improving control over MD, comparing three groups across three measurement points in time.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age above 18 years * MD diagnosis * Not being in any concurrent treatment for MD * English fluent * Daily access to the internet, and to a device with internet access * Give informed consent to the study * Respondents who reported being on a stable dose of medication for at least three months could take part in the study provided that they did not change their dosages while participating in the study. Exclusion Criteria: * Age under 18 years * No MD diagnosis * In concurrent psychology therapy for MD * Not fluent in English * Not having a daily internet access * Taking medication for less than three months

What they're measuring

Change from baseline in maladaptive daydreaming

Timeframe: Baseline, post, and follow-up (8 month total)

Change from baseline in daydreaming frequency

Timeframe: Baseline, post, and follow-up (8 month total)

Change from baseline in work and social adjustment

Timeframe: Baseline, post, and follow-up (8 month total)

Trial details

NCT IDNCT05235243

SponsorUniversity of Haifa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-02-03

View on ClinicalTrials.gov More Internet-Based Intervention trials